Using Non/Off-Targeted Therapies in Targeted Lung Cancer Populations episode artwork

EPISODE · Oct 16, 2014 · 25 MIN

Using Non/Off-Targeted Therapies in Targeted Lung Cancer Populations

from GRACEcast · host cancerGRACE Meetings

Acquired Resistance Forum Video #6: Dr. Nate Pennell of the Cleveland Clinic discussed the other options available to patients with ALK, ROS1 and EGFR lung cancer, such as chemotherapy, Avastin, and immunotherapy.

Episode metadata supplied by the publisher feed · Published Oct 16, 2014

Embed this episode

NOW PLAYING

Using Non/Off-Targeted Therapies in Targeted Lung Cancer Populations

0:00 25:14

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of GRACEcast?

This episode is 25 minutes long.

When was this GRACEcast episode published?

This episode was published on October 16, 2014.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!